HC Wainwright Has Negative Forecast for RNA Q2 Earnings
Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) – Stock analysts at HC Wainwright decreased their Q2 2025 earnings per share (EPS) estimates for shares of Avidity Biosciences in a report released on Monday, May 12th. HC Wainwright analyst A. Ghosh now anticipates that the biotechnology company will post earnings of ($0.61) per share for the […]
